577 related articles for article (PubMed ID: 15733744)
81. Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms.
Guo S
J Endocrinol; 2014 Feb; 220(2):T1-T23. PubMed ID: 24281010
[TBL] [Abstract][Full Text] [Related]
82. Molecular mechanisms involved in the adaptation to amino acid limitation in mammals.
Chaveroux C; Lambert-Langlais S; Cherasse Y; Averous J; Parry L; Carraro V; Jousse C; Maurin AC; Bruhat A; Fafournoux P
Biochimie; 2010 Jul; 92(7):736-45. PubMed ID: 20188139
[TBL] [Abstract][Full Text] [Related]
83. Differential actıvation and expression of insulin receptor substrate 1 (IRS1) in mononuclear cells of type 2 diabetes patients after insulin stimulation.
Gorgisen G; Balci MK; Celik FC; Gokkaya M; Ozdem S; Ozel D; Ozes ON
Cell Mol Biol (Noisy-le-grand); 2016 Feb; 62(2):25-30. PubMed ID: 26950447
[TBL] [Abstract][Full Text] [Related]
84. Insulin receptor substrate 1 overexpression promotes survival of glioblastoma cells through AKT1 activation.
Gorgisen G; Yaren Z
Folia Neuropathol; 2020; 58(1):38-44. PubMed ID: 32337956
[TBL] [Abstract][Full Text] [Related]
85. [Development of new antidiabetic drugs through the advanced knowledge of molecular biology in insulin signal transduction].
Kobayashi M; Hori H; Kawahara J
Nihon Rinsho; 2002 Sep; 60 Suppl 9():548-54. PubMed ID: 12387049
[No Abstract] [Full Text] [Related]
86. Novel silent variant (c1722G>A) in the coding region of the insulin receptor substrate 1 (IRS1) gene.
Kloos P; Mergenthaler S; Ranke MB; Wollmann HA; Eggermann T
Hum Mutat; 2000 Dec; 16(6):533. PubMed ID: 11102995
[No Abstract] [Full Text] [Related]
87. Insulin resistance: a phosphorylation-based uncoupling of insulin signaling.
Zick Y
Trends Cell Biol; 2001 Nov; 11(11):437-41. PubMed ID: 11684411
[TBL] [Abstract][Full Text] [Related]
88. Modulators of insulin action and their role in insulin resistance.
Pirola L; Johnston AM; Van Obberghen E
Int J Obes Relat Metab Disord; 2003 Dec; 27 Suppl 3():S61-4. PubMed ID: 14704748
[TBL] [Abstract][Full Text] [Related]
89. LPIN1 promotes epithelial cell transformation and mammary tumourigenesis via enhancing insulin receptor substrate 1 stability.
Kim JY; Kim G; Lim SC; Choi HS
Carcinogenesis; 2016 Dec; 37(12):1199-1209. PubMed ID: 27729374
[TBL] [Abstract][Full Text] [Related]
90. The P300 acetyltransferase inhibitor C646 promotes membrane translocation of insulin receptor protein substrate and interaction with the insulin receptor.
Peng J; Ramatchandirin B; Wang Y; Pearah A; Namachivayam K; Wolf RM; Steele K; MohanKumar K; Yu L; Guo S; White MF; Maheshwari A; He L
J Biol Chem; 2022 Mar; 298(3):101621. PubMed ID: 35074429
[TBL] [Abstract][Full Text] [Related]
91. The study of serine-threonine kinases.
Gorter G; Willem Akkerman J
Methods Mol Biol; 2004; 273():179-200. PubMed ID: 15308802
[No Abstract] [Full Text] [Related]
92. Involvement of insulin receptor substrates in cognitive impairment and Alzheimer's disease.
Tanokashira D; Fukuokaya W; Taguchi A
Neural Regen Res; 2019 Aug; 14(8):1330-1334. PubMed ID: 30964050
[TBL] [Abstract][Full Text] [Related]
93. Phosphorylation Codes in IRS-1 and IRS-2 Are Associated with the Activation/Inhibition of Insulin Canonical Signaling Pathways.
Martínez Báez A; Ayala G; Pedroza-Saavedra A; González-Sánchez HM; Chihu Amparan L
Curr Issues Mol Biol; 2024 Jan; 46(1):634-649. PubMed ID: 38248343
[TBL] [Abstract][Full Text] [Related]
94. The paradoxical regulation of protein phosphorylation in insulin action.
Saltiel AR
FASEB J; 1994 Oct; 8(13):1034-40. PubMed ID: 7926368
[TBL] [Abstract][Full Text] [Related]
95. Caged phosphoproteins.
Rothman DM; Petersson EJ; Vázquez ME; Brandt GS; Dougherty DA; Imperiali B
J Am Chem Soc; 2005 Jan; 127(3):846-7. PubMed ID: 15656617
[TBL] [Abstract][Full Text] [Related]
96. Phosphoinositides in insulin action and diabetes.
Bridges D; Saltiel AR
Curr Top Microbiol Immunol; 2012; 362():61-85. PubMed ID: 23086413
[TBL] [Abstract][Full Text] [Related]
97. High risk genetic variants of human insulin receptor substrate 1(IRS1) infer structural instability and functional interference.
Bhattacharjee A; Pranto SMAM; Ahammad I; Chowdhury ZM; Juliana FM; Das KC; Keya CA; Salimullah M
J Biomol Struct Dyn; 2023; 41(24):15150-15164. PubMed ID: 36907599
[TBL] [Abstract][Full Text] [Related]
98. [The role of peroxisome proliferator activated receptors in metabolic balance disturbances under stress].
Dushkin MI; Khrapova MV
Usp Fiziol Nauk; 2011; 42(2):3-24. PubMed ID: 21735702
[TBL] [Abstract][Full Text] [Related]
99. Robust adaptation of PKC
Joshi DM; Patel J; Bhatt H
Biomed Phys Eng Express; 2021 Aug; 7(5):. PubMed ID: 34315137
[TBL] [Abstract][Full Text] [Related]
100. Identification of novel mutations of Insulin Receptor Substrate 1 (IRS1) in tumor samples of non-small cell lung cancer (NSCLC): Implications for aberrant insulin signaling in development of cancer.
Gorgisen G; Hapil FZ; Yilmaz O; Cetin Z; Pehlivanoglu S; Ozbudak IH; Erdogan A; Ozes ON
Genet Mol Biol; 2019; 42(1):15-25. PubMed ID: 30807634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
